Recruiting

Neuroblastic Tumor

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT00588068

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Tumor and Marrow Markers

Study Details

Brief summary:

The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and your serum tested for anti-tumor antibodies.

Conditions

Neuroblastoma

Study ID

NCT00588068

Start date

Sep 26, 2000

Status verified date

Oct, 2025

Completion date

Sep, 2026

Anticipated

Primary completion date

Sep, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma Staging System

OR

  • Clinically suspected neuroblastic tumors.

PK DRAW INCLUSION CRITERIA (FOR PK DRAWS ONLY):

PK Draw Inclusion Criteria

  • Patients who receive naxitamab as part of their standard of care

Exclusion Criteria:

  • None

Study Design

Enrollment

2070 participants

Anticipated

Interventions and Outcome Measures

Arms

1

Tumor and Marrow Markers

Interventions

Tumor and Marrow Markers

Tumor and Marrow Markers

Primary outcome measure

  • To study the molecular-genetic makeup and metastasis of neuroblastic tumors. [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Nai-Kong Cheung, M.D., Ph.D.

646-888-2313

Shakeel Modak, MD

212-639-7623

Locations

Memorial Sloan Kettering Cancer Center

Recruiting

New York, New York, United States, 10065

Principal Investigator:

Nai-Kong Cheung, M.D., Ph.D.

More Information

Sponsor

Memorial Sloan Kettering Cancer Center

Last update posted

Oct 15, 2025

Last verified

Oct, 2025

Keywords

  • Adrenal Gland
  • No stage requirement

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-10-15.